|
ILF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.515050E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.584190E-03 |
| Normal-vs-Stage2 |
1.528350E-02 |
| Normal-vs-Stage3 |
4.032000E-02 |
| Normal-vs-Stage4 |
2.058100E-02 |
| Stage1-vs-Stage2 |
6.253000E-01 |
| Stage1-vs-Stage3 |
4.529800E-01 |
| Stage1-vs-Stage4 |
9.951200E-01 |
| Stage2-vs-Stage3 |
3.782600E-01 |
| Stage2-vs-Stage4 |
7.038000E-01 |
| Stage3-vs-Stage4 |
6.186400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.139100E-03 |
| Normal-vs-AfricanAmerican |
7.844000E-01 |
| Normal-vs-Asian |
7.140300E-03 |
| Caucasian-vs-AfricanAmerican |
1.985040E-01 |
| Caucasian-vs-Asian |
4.114400E-01 |
| AfricanAmerican-vs-Asian |
6.909900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.159100E-03 |
| Normal-vs-Female |
2.519900E-03 |
| Male-vs-Female |
6.712400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.657800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.644570E-03 |
| Normal-vs-Age(61-80Yrs) |
1.634460E-02 |
| Normal-vs-Age(81-100Yrs) |
3.912400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.928200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.959200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.018100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.637600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.914300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.155180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.153600E-01 |
| Classical-VS-Follicular |
1.000440E-04 |
| Classical-VS-Other |
3.049200E-01 |
| Classical-VS-Normal |
8.303700E-02 |
| Tall-VS-Follicular |
7.291800E-02 |
| Tall-VS-Other |
3.162200E-01 |
| Tall-VS-Normal |
8.345600E-02 |
| Follicular-VS-Other |
9.553600E-01 |
| Follicular-VS-Normal |
2.83020000002576E-06 |
| Other-VS-Normal |
1.651590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.159000E-04 |
| Normal-vs-N1 |
3.993400E-04 |
| N0-vs-N1 |
1.948200E-01 |
|
|
